Literature DB >> 11404475

Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP.

M J Czar1, E N Kersh, L A Mijares, G Lanier, J Lewis, G Yap, A Chen, A Sher, C S Duckett, R Ahmed, P L Schwartzberg.   

Abstract

We have introduced a targeted mutation in SH2D1A/DSHP/SAP, the gene responsible for the human genetic disorder X-linked lymphoproliferative disease (XLP). SLAM-associated protein (SAP)-deficient mice had normal lymphocyte development, but on challenge with infectious agents, recapitulated features of XLP. Infection of SAP- mice with lymphocyte choriomeningitis virus (LCMV) or Toxoplasma gondii was associated with increased T cell activation and IFN-gamma production, as well as a reduction of Ig-secreting cells. Anti-CD3-stimulated splenocytes from uninfected SAP- mice produced increased IFN-gamma and decreased IL-4, findings supported by decreased serum IgE levels in vivo. The Th1 skewing of these animals suggests that cytokine misregulation may contribute to phenotypes associated with mutation of SH2D1A/SAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404475      PMCID: PMC34689          DOI: 10.1073/pnas.131193098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.

Authors:  G S Yap; A Sher
Journal:  Immunobiology       Date:  1999-12       Impact factor: 3.144

2.  CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.

Authors:  S V Mikhalap; L M Shlapatska; A G Berdova; C L Law; E A Clark; S P Sidorenko
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

3.  Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; W E Paul; A Sher
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

4.  Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.

Authors:  A G Castro; T M Hauser; B G Cocks; J Abrams; S Zurawski; T Churakova; F Zonin; D Robinson; S G Tangye; G Aversa; K E Nichols; J E de Vries; L L Lanier; A O'Garra
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Authors:  J Sumegi; D Huang; A Lanyi; J D Davis; T A Seemayer; A Maeda; G Klein; M Seri; H Wakiguchi; D T Purtilo; T G Gross
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

6.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.

Authors:  S G Tangye; S Lazetic; E Woollatt; G R Sutherland; L L Lanier; J H Phillips
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.

Authors:  S G Tangye; J H Phillips; L L Lanier; K E Nichols
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

8.  The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.

Authors:  B S Sylla; K Murphy; E Cahir-McFarland; W S Lane; G Mosialos; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Defective NK cell activation in X-linked lymphoproliferative disease.

Authors:  L Benoit; X Wang; H F Pabst; J Dutz; R Tan
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

10.  X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.

Authors:  S Parolini; C Bottino; M Falco; R Augugliaro; S Giliani; R Franceschini; H D Ochs; H Wolf; J Y Bonnefoy; R Biassoni; L Moretta; L D Notarangelo; A Moretta
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  93 in total

Review 1.  Genetic approaches to tyrosine kinase signaling pathways in the immune system.

Authors:  Pamela L Schwartzberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

3.  Defective B cell responses in the absence of SH2D1A.

Authors:  Massimo Morra; Robert A Barrington; Ana C Abadia-Molina; Susumo Okamoto; Aimee Julien; Charles Gullo; Anuj Kalsy; Matthew J Edwards; Gang Chen; Rosanne Spolski; Warren J Leonard; Brigitte T Huber; Persephone Borrow; Christine A Biron; Abhay R Satoskar; Michael C Carroll; Cox Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

Review 4.  X-linked lymphoproliferative disease: genetic lesions and clinical consequences.

Authors:  Andrew J MacGinnitie; Raif Geha
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

5.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 6.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 7.  Target identification and validation in systemic autoimmunity.

Authors:  Stanford L Peng
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  X-linked lymphoproliferative disease in an adult.

Authors:  Takumi Hoshino; Hirokazu Kanegane; Noriko Doki; Hiroyuki Irisawa; Tohru Sakura; Yoshihisa Nojima; Shuichi Miyawaki; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease.

Authors:  Christine Rivat; Claire Booth; Maria Alonso-Ferrero; Michael Blundell; Neil J Sebire; Adrian J Thrasher; H Bobby Gaspar
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

Review 10.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.